AMGN Amgen Inc
P/E
27.18
Forward P/E
19.49
Price/Sales
6.14
Beta
0.413
Div Yield
0.0224%
Market Cap
--
Company Analysis
Latest News
Amgen Inc Q1 2026 Earnings Preview: What Analysts Expect on April 30, 2026
Amgen is expected to report Q1 2026 revenue of $8.67 billion and adjusted EPS of $4.75, with its current $344.55 share price trading roughly 3.4% below the...
OpenAI Launches GPT-Rosalind with Moderna and Amgen, Targeting Faster Drug Discovery
OpenAI launched GPT-Rosalind, a new series of AI models engineered to accelerate life sciences research. The tool assists scientists in synthesizing evidence,...